Omega Therapeutics, Inc.
OMGA
Revenue
2.13M
▼-226.00k▼-9.58%
3 Months ChangeAssets
168.23M
▼-15.46M▼-8.41%
3 Months ChangeLiabilities
141.96M
▼-363.00k▼-0.2550%
3 Months ChangeFree Cash Flow
-12.34M
▲11.16M▲47.49%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-04
Form 8-K
ID: 0000950170-24-112962
2024-08-30
Form 8-K
ID: 0000950170-24-102313
2024-08-06
Form 10-Q
ID: 0000950170-24-091197
2024-08-06
Form 8-K
ID: 0000950170-24-091196
2024-06-24
Form 8-K
ID: 0000950170-24-076685
2024-05-30
Form 8-K
ID: 0000950170-24-066746
2024-05-06
Form 10-Q
ID: 0000950170-24-053198
2024-05-06
Form 8-K
ID: 0000950170-24-053194
2024-04-16
Form 8-K
ID: 0000950170-24-044795
2024-03-28
Form 8-K
ID: 0000950170-24-038053